Zenas BioPharma, Inc.Zenas BioPharma, Inc.Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

No trades
See on Supercharts

Price target

36.200.000.00%
The 5 analysts offering 1 year price forecasts for ZBIO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to ZBIO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ZBIO EPS for the last quarter is −5.02 USD despite the estimation of −0.95 USD. In the next quarter EPS is expected to reach −1.01 USD. Track more of Zenas BioPharma, Inc. financials and stay on top of what is up with the company.
In the next quarter Zenas BioPharma, Inc. revenue is expected to reach 0.00 USD. Check out Zenas BioPharma, Inc. revenue and earnings and make informed decisions.
According to analysts, ZBIO price target is 36.20 USD with a max estimate of 45.00 USD and a min estimate of 27.00 USD. Check if this forecast comes true in a year, meanwhile watch Zenas BioPharma, Inc. stock price chart and keep track of the current situation with ZBIO news and stock market news.
We've gathered opinions of 5 analysts rating ZBIO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.